pith. sign in

arxiv: 2607.01105 · v1 · pith:YFD7SB75new · submitted 2026-07-01 · 💻 cs.LG

SynLaD: Latent Diffusion for Generating Synthesizable Molecules Conditioned on 3D Pharmacophore Profiles

Miruna Cretu , John Bradshaw , Patricia Suriana , Saeed Saremi , Omar Mahmood , Kirill Shmilovich , Kangway Chuang , Vishnu Sresht
show 1 more author
Colin Grambow
This is my paper

Pith reviewed 2026-07-02 15:39 UTC · model grok-4.3

classification 💻 cs.LG
keywords molecular generationlatent diffusionsynthesizable moleculespharmacophore conditioningdrug design3D molecular designsynthesis routesdiffusion models
0
0 comments X

The pith

A single latent diffusion model generates both 3D molecular shapes aligned to pharmacophore profiles and feasible synthesis routes for those molecules.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper introduces SynLaD to address the split between designing molecules that fit a desired 3D shape and ensuring those molecules can actually be made in the lab. It does this by training an encoder to place molecules in a latent space that two separate decoder heads can read: one head rebuilds the atom types and 3D coordinates, while the other produces a step-by-step synthesis route. A diffusion transformer then creates new points in that same latent space, guided only by the input pharmacophore profile. The resulting molecules are evaluated on analogue-generation tasks for known bioactive ligands, where the model produces more synthesizable and diverse candidates than prior methods. If the approach holds, drug-design workflows could move from separate shape and synthesis steps to a unified generation process that directly outputs makeable compounds.

Core claim

SynLaD learns a latent space in which molecules are represented so that a geometric decoder head can reconstruct atom types and coordinates while an autoregressive decoder head can output valid synthesis routes in serialized reaction notation; a diffusion transformer then samples new latent vectors conditioned on pharmacophore profiles, allowing the same model to produce molecules that are both shape-aligned and synthetically accessible.

What carries the argument

Dual-head decoder attached to a shared latent space, where one head reconstructs 3D atom types and coordinates and the other generates autoregressive synthesis routes, so that diffusion sampling under pharmacophore conditioning satisfies both constraints at once.

If this is right

  • Molecules are produced together with their synthesis plans, removing the need for separate post-hoc route planning.
  • The model achieves higher counts of synthesizable and diverse hits than existing baselines on analogue generation tasks.
  • Pharmacophore conditioning directly controls 3D shape without requiring later adjustments that might break synthetic feasibility.
  • Reaction constraints are enforced inside the generative model rather than applied after sampling.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The joint latent space could allow synthesis feasibility to influence shape choices during generation rather than after the fact.
  • Replacing or adding other conditioning signals, such as predicted binding scores, would test whether the same architecture generalizes beyond pharmacophores.
  • End-to-end training from profile to route might reduce the number of design-make-test cycles needed in practice.
  • Checking whether the generated routes actually succeed in the laboratory would provide a direct test of real-world utility beyond in silico metrics.

Load-bearing premise

A single learned latent space can simultaneously support accurate 3D geometric reconstruction and valid autoregressive synthesis route generation when conditioned on pharmacophore profiles.

What would settle it

If generated analogues for a benchmark set of bioactive ligands show lower rates of both pharmacophore shape match and successful synthesis-route validity than the strongest baseline methods, the performance advantage would not hold.

Figures

Figures reproduced from arXiv: 2607.01105 by Colin Grambow, John Bradshaw, Kangway Chuang, Kirill Shmilovich, Miruna Cretu, Omar Mahmood, Patricia Suriana, Saeed Saremi, Vishnu Sresht.

Figure 1
Figure 1. Figure 1: A, Overview of SynLaD: a multi-head generative model that jointly produces 3D molecular structures and synthesis plans. SynLaD is trained in two stages: ① an autoencoder learns a latent representation of 3D molecules, with an auxiliary decoder that generates a synthesis plan for each structure. ② a pharmacophore-conditioned diffusion model learns to sample latents that decode to molecules containing a desi… view at source ↗
Figure 2
Figure 2. Figure 2: Cross-decoder agreement on generated samples. We evaluate similarities between synthesis- and 3D-decoded molecules obtained from the same latent. As a control, we also report ROCS Tanimoto Shape/Color scores for randomly paired synthesis- and 3D-decoded molecules, illustrating the similarity expected in the absence of cross-decoder coupling. 6 [PITH_FULL_IMAGE:figures/full_fig_p006_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: Pharmacophore conditioned generation. Metrics are evaluated for 50 random conditioning queries from a held-out set and 100 samples from SynLaD for each conditioning pharmacophore. Left: Values for hits, unique scaffold hits, and max score are medians across the 50 query molecules, while AiZynth is a mean (higher is better). Max score represents the maximum Tanimoto combo score for generated samples. Right:… view at source ↗
Figure 4
Figure 4. Figure 4: Bioactive hit diversification. Structural analogues are generated for 10 Lit-PCBA ligands using SynLaD and baseline methods. We report (1) the distribution of aggregated Tanimoto shape and color similarity scores to the query, and (2) the number of hits per query for each method, highlighting the fraction of synthesizable hits. in average number of synthesizable hits. Although REINVENT achieves the highest… view at source ↗
Figure 5
Figure 5. Figure 5: Bioactive hit diversification experiment. Examples of molecules generated by our model with annotated shape and phar￾macophore overlap. The right-hand side shows the native ligand (gray) overlaid with the docked generated molecule (orange). 8 [PITH_FULL_IMAGE:figures/full_fig_p008_5.png] view at source ↗
Figure 6
Figure 6. Figure 6: A tokenization scheme for describing synthesis plans in a bottom-up manner similar to Bradshaw et al. (2020). The synthesis plan, depicted as a DAG in A can be serialized as shown in B into a series of tokens. In B, the four dotted circles above the sequence indicate the state of the synthesis plan at that stage of decoding—empty nodes indicate the identity of the molecule corresponding to that node has ye… view at source ↗
Figure 7
Figure 7. Figure 7: Unconditional generation: synthesis- vs. 3D-decoded outputs. Examples of decoded outputs from the synthesis decoder, followed by outputs of the 3D decoder, from the same latent [PITH_FULL_IMAGE:figures/full_fig_p022_7.png] view at source ↗
Figure 8
Figure 8. Figure 8: Dataset screen vs. SynLaD sampling. We report the number of unique hits for randomly selected queries from the test set. See the “Screening case study” section in the main text for further details. 22 [PITH_FULL_IMAGE:figures/full_fig_p022_8.png] view at source ↗
Figure 9
Figure 9. Figure 9: SynLaD outputs for the Lit-PCBA conditioning task. We visualize the Lit-PCBA ligand used as the conditioning Query (via its pharmacophore), together with the corresponding 3D decoder output and the synthesis decoder output (final product and entire pathway). For readability, the query and 3D-decoded molecules are shown in 2D, although both are modeled in 3D coordinate space. We intentionally select example… view at source ↗
Figure 10
Figure 10. Figure 10: Examples of query (reference) and sampled molecules conditioned on pharmacophores. Samples were decoded using the 3D decoder, and we show the molecules in their predicted conformation. 24 [PITH_FULL_IMAGE:figures/full_fig_p024_10.png] view at source ↗
Figure 11
Figure 11. Figure 11: Bioactive hit difersification experiment. We add to the results in [PITH_FULL_IMAGE:figures/full_fig_p025_11.png] view at source ↗
Figure 12
Figure 12. Figure 12: Bioactive hit difersification experiment. Tanimoto distances of Lit-PCBA ligands to our training set. 25 [PITH_FULL_IMAGE:figures/full_fig_p025_12.png] view at source ↗
Figure 13
Figure 13. Figure 13: Removing the 3D VAE and diffusion module. To assess the importance of our model’s autoencoder structure and 3D components, we run an ablation where we remove these. Here, as shown, we instead train a model to map directly from a pharmacophore to a synthesis plan via a deterministic hidden representation, Z ′ . For consistency with SynLaD, we keep the pharmacophore embedding network the same as that used a… view at source ↗
Figure 14
Figure 14. Figure 14: Effect of removing the 3D branch on the number of hits. We generate molecules conditioned on a pharmacophore with 1) SynLaD and a 2) synthesis decoder directly conditioned on the pharmacophore embedding. REINVENT We used the official implementation of REINVENT 4 available at https://github.com/Molec ularAI/REINVENT4 (Loeffler et al., 2024; Blaschke et al., 2020; Olivecrona et al., 2017). We start from the… view at source ↗
Figure 15
Figure 15. Figure 15: Effect of removing the 3D branch on the number of hits, for our OOD hit diversification experiment. We replicate the setting in [PITH_FULL_IMAGE:figures/full_fig_p028_15.png] view at source ↗
read the original abstract

We present SynLaD, a latent diffusion framework for small-molecule generation that unifies ligand-based drug design objectives (what to make) with synthetic accessibility (how to make it). Current models typically optimize one objective at the expense of the other, creating a bottleneck for discovering high-scoring and synthesizable molecules. SynLaD combines reaction-constrained generation with pharmacophore-conditioned 3D design by learning a latent space that decodes to both 3D structures and synthesis pathways. An encoder maps molecules to a latent representation used by two decoder heads: (i) a geometric head that reconstructs atom types and coordinates and (ii) an autoregressive synthesis head that outputs synthetic routes in a serialized, reaction-based notation. A diffusion transformer generates novel latents in the learned space, conditioned on pharmacophore profiles. Across analogue generation tasks for bioactive ligands, SynLaD outperforms existing baselines in synthesizable and diverse hit generation, demonstrating that a single model can produce shape-aligned molecules with feasible synthesis plans.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 1 minor

Summary. The manuscript introduces SynLaD, a latent diffusion framework that unifies 3D pharmacophore-conditioned molecule generation with synthetic accessibility. An encoder produces a shared latent representation decoded by a geometric head (atom types and coordinates) and an autoregressive synthesis head (serialized reaction routes); a diffusion transformer then samples novel latents conditioned on pharmacophore profiles. The central empirical claim is that this single model outperforms existing baselines on analogue generation tasks for bioactive ligands by producing more synthesizable and diverse hits.

Significance. If the reported outperformance is robustly supported, the work would be significant for ligand-based drug design by removing the typical trade-off between 3D shape matching and synthetic feasibility. The dual-decoder architecture in a conditioned latent diffusion setting is a substantive architectural proposal that could influence subsequent generative models if the joint training objectives are shown to be compatible.

major comments (2)
  1. [Abstract] Abstract: the claim that SynLaD 'outperforms existing baselines in synthesizable and diverse hit generation' is presented without any quantitative metrics, error bars, dataset sizes, or baseline names, which is load-bearing for the central empirical contribution and leaves the performance assertion unverifiable from the provided text.
  2. [Abstract] Abstract: the core modeling assumption that a single learned latent space can simultaneously support accurate 3D geometric reconstruction and valid autoregressive synthesis-route generation under pharmacophore conditioning is stated without reference to any ablation, conflict analysis, or reconstruction metrics that would demonstrate compatibility of the two decoder heads.
minor comments (1)
  1. [Abstract] Abstract: the phrase 'reaction-constrained generation' is introduced without a brief definition or citation, reducing immediate clarity for readers unfamiliar with the notation.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the detailed and constructive comments. We address each major comment below and will revise the abstract accordingly to improve clarity and verifiability.

read point-by-point responses

  1. Referee: [Abstract] Abstract: the claim that SynLaD 'outperforms existing baselines in synthesizable and diverse hit generation' is presented without any quantitative metrics, error bars, dataset sizes, or baseline names, which is load-bearing for the central empirical contribution and leaves the performance assertion unverifiable from the provided text.

    Authors: We agree that the abstract should include specific supporting details for the performance claim. In the revised manuscript we will update the abstract to report key quantitative results from the analogue generation experiments (e.g., improvement in synthesizability and diversity metrics with error bars), the dataset sizes used, and the names of the compared baselines. revision: yes

  2. Referee: [Abstract] Abstract: the core modeling assumption that a single learned latent space can simultaneously support accurate 3D geometric reconstruction and valid autoregressive synthesis-route generation under pharmacophore conditioning is stated without reference to any ablation, conflict analysis, or reconstruction metrics that would demonstrate compatibility of the two decoder heads.

    Authors: The abstract currently does not reference supporting analyses. While the manuscript body contains ablation studies and reconstruction metrics for the dual-decoder setup, we will revise the abstract to briefly cite the empirical evidence of compatibility (low joint reconstruction error and absence of objective conflicts) so that the modeling assumption is grounded in the abstract itself. revision: yes

Circularity Check

0 steps flagged

No significant circularity; empirical model with external baselines

full rationale

The paper describes a latent diffusion model with an encoder producing a shared latent space, two decoder heads (geometric reconstruction and autoregressive synthesis route generation), and a diffusion transformer conditioned on pharmacophore profiles. All performance claims rest on empirical comparisons to external baselines on analogue generation tasks for bioactive ligands, with no equations, fitted parameters renamed as predictions, self-definitional loops, or load-bearing self-citations visible in the architecture or results description. The derivation chain is self-contained as a standard trained generative model evaluated against independent benchmarks.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

Abstract-only review provides no equations, training details, or dataset descriptions, so no specific free parameters, axioms, or invented entities can be identified.

pith-pipeline@v0.9.1-grok · 5741 in / 1213 out tokens · 20370 ms · 2026-07-02T15:39:35.558010+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

12 extracted references · 11 canonical work pages

  1. [1]

    Bemis, G

    URL https://openreview.net/forum ?id=KSLkFYHlYg. Bemis, G. W. and Murcko, M. A. The properties of known drugs. 1. Molecular frameworks.Journal of Medicinal Chemistry, 39(15):2887–2893, 1996. URL https:// doi.org/10.1021/jm9602928. Bengio, Y ., Ducharme, R., Vincent, P., and Jauvin, C. A neural probabilistic language model.Journal of Machine Learning Resea...

    work page doi:10.1021/jm9602928 1996

  2. [3]

    Genheden, S., Thakkar, A., Chadimová, V ., Reymond, J

    URL https://www.pnas.org/doi/abs /10.1073/pnas.2415665122. Genheden, S., Thakkar, A., Chadimová, V ., Reymond, J. L., Engkvist, O., and Bjerrum, E. AiZynthFinder: a fast, ro- bust and flexible open-source software for retrosynthetic planning.Journal of Cheminformatics, 12:70, 2020. URL https://doi.org/10.1186/s13321-020-0 0472-1. Gobbi, A. and Poppinger, ...

    work page doi:10.1073/pnas.2415665122 2020

  3. [4]

    Gottipati, S

    URL https://doi.org/10.1016/S007 9-6468(06)45501-6. Gottipati, S. K., Sattarov, B., Niu, S., Pathak, Y ., Wei, H., Liu, S., Liu, S., Blackburn, S., Thomas, K., Coley, C., Tang, J., Chandar, S., and Bengio, Y . Learning to nav- igate the synthetically accessible chemical space using reinforcement learning. In Daumé III, H. and Singh, A. (eds.),Proceedings ...

    work page doi:10.1016/s007 2020

  4. [5]

    Hawkins, P

    URL https://doi.org/10.1371/jour nal.pcbi.1002380. Hawkins, P. C. D., Skillman, A. G., and Nicholls, A. Com- parison of shape-matching and docking as virtual screen- ing tools.Journal of Medicinal Chemistry, 50(1):74–82,

    work page doi:10.1371/jour

  5. [6]

    Hawkins, P

    URL https://doi.org/10.1021/jm06 03365. Hawkins, P. C. D., Skillman, A. G., Warren, G. L., Elling- son, B. A., and Stahl, M. T. Conformer generation with OMEGA: Algorithm and validation using high quality structures from the protein databank and cam- bridge structural database.Journal of Chemical In- formation and Modeling, 50(4):572–584, 2010. URL https:...

    work page doi:10.1021/jm06 2010

  6. [7]

    Imrie, F., Hadfield, T

    URL https://openaccess.thecvf.co m/content/CVPR2025/papers/Huang_MIDI _Multi-Instance_Diffusion_for_Single _Image_to_3D_Scene_Generation_CVPR_2 025_paper.pdf. Imrie, F., Hadfield, T. E., Bradley, A. R., and Deane, C. M. Deep generative design with 3D pharmacophoric con- straints.Chemical Science, 12:14577–14589, 2021. URL http://dx.doi.org/10.1039/D1SC024...

    work page doi:10.1039/d1sc02436a 2021

  7. [8]

    Kingma, D

    URL https://doi.org/10.1021/ci20 0207y. Kingma, D. P. and Welling, M. Auto-encoding variational Bayes, 2013. URL https://arxiv.org/abs/13 12.6114. Korovina, K., Xu, S., Kandasamy, K., Neiswanger, W., Poc- zos, B., Schneider, J., and Xing, E. ChemBO: Bayesian optimization of small organic molecules with synthe- sizable recommendations. In Chiappa, S. and C...

    work page doi:10.1021/ci20 2013

  8. [9]

    Le, T., Cremer, J., Noe, F., Clevert, D.-A., and Schütt, K

    URL https://doi.org/10.1002/wcms .1678. Le, T., Cremer, J., Noe, F., Clevert, D.-A., and Schütt, K. T. Navigating the design space of equivariant diffusion- based generative models for de novo 3D molecule gener- ation. InThe Twelfth International Conference on Learn- ing Representations, 2024. URL https://openre view.net/forum?id=kzGuiRXZrQ. Lee, S., Krei...

    work page doi:10.1002/wcms 2024

  9. [10]

    Rekesh, A., Cretu, M., Shevchuk, D., Somnath, V

    URL https://openreview.net/forum ?id=KPRIwWhqAZ. Rekesh, A., Cretu, M., Shevchuk, D., Somnath, V . R., Liò, P., Batey, R. A., Tyers, M., Koziarski, M., and Liu, C.- H. SynCoGen: Synthesizable 3D molecule generation via joint reaction and coordinate modeling, 2025. URL https://arxiv.org/abs/2507.11818. Rezende, D. and Mohamed, S. Variational inference with...

    work page doi:10.1109/cvpr52688.20 2025

  10. [11]

    Found in Translation

    URL https://openreview.net/forum ?id=g3VCIM94ke. Schwaller, P., Gaudin, T., Lanyi, D., Bekas, C., and Laino, T. “Found in Translation”: predicting outcomes of complex organic chemistry reactions using neural sequence-to- sequence models.Chemical Science, 9(28):6091–6098,

  11. [12]

    Schwaller, P., Laino, T., Gaudin, T., Bolgar, P., Hunter, C

    URL https://doi.org/10.1039/C8SC 02339E. Schwaller, P., Laino, T., Gaudin, T., Bolgar, P., Hunter, C. A., Bekas, C., and Lee, A. A. Molecular Transformer: A model for uncertainty-calibrated chemical reaction pre- diction.ACS Central Science, 5(9):1572–1583, 2019. URL https://doi.org/10.1021/acscents ci.9b00576. Segler, M. H., Kogej, T., Tyrchan, C., and W...

    work page doi:10.1039/c8sc 2019

  12. [13]

    building block

    URL https://doi.org/10.1021/acs. jcim.1c01065. Seo, S., Kim, M., Shen, T., Ester, M., Park, J., Ahn, S., and Kim, W. Y . Generative flows on synthetic pathway for drug design. InThe Thirteenth International Conference on Learning Representations, 2025. URL https://op enreview.net/forum?id=pB1XSj2y4X. 14 SynLaD : Latent Diffusion for Generating Synthesizab...

    work page doi:10.1021/acs 2025